X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse SUVEN LIFE with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFE   TEVA PHARMA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
TEVA PHARMA
Dec-13
SUVEN LIFE/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs2512,905-   
Low Rs1552,524-   
Sales per share (Unadj.) Rs49.11,667.3-  
Earnings per share (Unadj.) Rs9.7104.2-  
Cash flow per share (Unadj.) Rs11.4238.9-  
Dividends per share (Unadj.) Rs1.5091.18-  
Dividend yield (eoy) %0.73.4 22.0%  
Book value per share (Unadj.) Rs60.31,852.0-  
Shares outstanding (eoy) m127.28848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.11.6 253.7%   
Avg P/E ratio x20.926.1 80.1%  
P/CF ratio (eoy) x17.811.4 156.8%  
Price / Book Value ratio x3.41.5 229.6%  
Dividend payout %15.487.5 17.6%   
Avg Mkt Cap Rs m25,8252,301,811 1.1%   
No. of employees `0001.144.9 2.4%   
Total wages/salary Rs m6130-   
Avg. sales/employee Rs Th5,832.631,457.4 18.5%   
Avg. wages/employee Rs Th571.50-   
Avg. net profit/employee Rs Th1,153.81,965.1 58.7%   
INCOME DATA
Net Sales Rs m6,2531,413,854 0.4%  
Other income Rs m2330-   
Total revenues Rs m6,4851,413,854 0.5%   
Gross profit Rs m1,982387,185 0.5%  
Depreciation Rs m213114,283 0.2%   
Interest Rs m4627,770 0.2%   
Profit before tax Rs m1,955245,131 0.8%   
Minority Interest Rs m01,114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-160,915 0.0%   
Tax Rs m718-2,993 -24.0%   
Profit after tax Rs m1,23788,322 1.4%  
Gross profit margin %31.727.4 115.7%  
Effective tax rate %36.7-1.2 -3,009.0%   
Net profit margin %19.86.2 316.7%  
BALANCE SHEET DATA
Current assets Rs m5,622954,912 0.6%   
Current liabilities Rs m1,168832,764 0.1%   
Net working cap to sales %71.28.6 824.7%  
Current ratio x4.81.1 419.9%  
Inventory Days Days8191 89.7%  
Debtors Days Days3696 37.5%  
Net fixed assets Rs m3,325461,796 0.7%   
Share capital Rs m1273,480 3.7%   
"Free" reserves Rs m7,5470-   
Net worth Rs m7,6741,570,524 0.5%   
Long term debt Rs m14722,935 0.0%   
Total assets Rs m9,1353,231,110 0.3%  
Interest coverage x43.29.8 439.9%   
Debt to equity ratio x00.5 0.4%  
Sales to assets ratio x0.70.4 156.4%   
Return on assets %14.03.6 390.9%  
Return on equity %16.15.6 286.6%  
Return on capital %26.04.9 527.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m3,0650-   
CASH FLOW
From Operations Rs m699225,295 0.3%  
From Investments Rs m-6-79,831 0.0%  
From Financial Activity Rs m-577-270,257 0.2%  
Net Cashflow Rs m116-124,793 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 69.6 Rs / USD

Compare SUVEN LIFE With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare SUVEN LIFE With: ABBOTT INDIA  FDC LTD.  CADILA HEALTHCARE  IPCA LABS  PANACEA BIOTECH  



Today's Market

Sensex, Nifty Close at Record Highs; Healthcare and Power Stocks Witness Buying(Closing)

Indian share markets continued to trade on a flat during closing hours of trade and ended the day marginally higher to close at fresh record high levels.

Related Views On News

SUVEN LIFE Surges by 12%; BSE HEALTHCARE Index Up 1.1% (Market Updates)

Aug 21, 2018 | Updated on Aug 21, 2018

SUVEN LIFE share price has surged by 12% and its current market price is Rs 261. The BSE HEALTHCARE is up by 1.1%. The top gainers in the BSE HEALTHCARE Index is SUVEN LIFE (up 12.2%). The top losers are JUBILANT LIFE SCIENCES (down 0.2%) and GRANULES INDIA (down 0.4%).

BSE Sensex at All Time High; COAL INDIA Among Top Gainers (Market Updates)

Aug 21, 2018 | Updated on Aug 21, 2018

The BSE Sensex is trading at its all-time high of 38,323 (up 0.1%). Among the top gainers in the BSE Sensex today is COAL INDIA. In the meantime, the NSE Nifty is trading at 11,572 (up 0.2 %).

SUVEN LIFE Surges by 5%; BSE HEALTHCARE Index Up 1.1% (Market Updates)

Aug 21, 2018 | Updated on Aug 21, 2018

SUVEN LIFE share price has surged by 5% and its current market price is Rs 245. The BSE HEALTHCARE is up by 1.1%. The top gainers in the BSE HEALTHCARE Index is SUVEN LIFE (up 5.5%). The top losers are NATCO PHARMA and FORTIS HEALTHCARE (down 0.2%).

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 21, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS